Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

11,984 total articles

Major Shareholder Sells Stock in Sensei Biotherapeutics Amid Clinical Progress and Analyst Optimism

Major Shareholder Sells Stock in Sensei Biotherapeutics Amid Clinical Progress and Analyst Optimism

A significant transaction was reported involving a major shareholder in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE). On June 1, 2026, James Peyer, who holds a ten percent ownership stake in the company, sold shares totaling $500,542. This sale occurred while the stock had seen substantial gains, rising nearly 19% over the preceding week and trading …

Newegg Director Sells Shares Following Volatile Trading Period

Newegg Director Sells Shares Following Volatile Trading Period

Fred Faching Chang, a director and significant shareholder of Newegg Commerce, Inc. (NASDAQ:NEGG), executed two notable sales of company common stock in late May. These reported insider transactions suggest activity from an internal stakeholder amid the stock's highly volatile trading history. The total value of the shares sold across these transac…

Evergy Director Sells Stock Amid Strong Q1 Performance

Evergy Director Sells Stock Amid Strong Q1 Performance

Director Sandra AJ Lawrence of Evergy, Inc. (NASDAQ:EVRG) executed stock sales totaling $96,215 worth of common shares across two separate transactions during the end of May. These details were documented in a Form 4 filing submitted to the Securities and Exchange Commission on June 1, 2026.The divestiture occurred over two days: on May 28, Ms. Law…

Processa Pharmaceuticals Officer Buys Shares Amid Stock Decline

Processa Pharmaceuticals Officer Buys Shares Amid Stock Decline

Wendy Guy, Chief Administrative Officer at Processa Pharmaceuticals, Inc., recently acquired a block of shares in the company. The purchase occurred on May 29, 2026. This insider transaction is noteworthy given that the stock has experienced a significant decline over the past six months, though current analysis suggests potential undervaluation.

TREACE MEDICAL CONCEPTS CEO Purchases Shares Amid Stock Gains; Q1 Results and Corporate Governance Developments Reported

TREACE MEDICAL CONCEPTS CEO Purchases Shares Amid Stock Gains; Q1 Results and Corporate Governance Developments Reported

John T. Treace, a principal officer and director of TREACE MEDICAL CONCEPTS, INC., recently acquired a significant block of the company's common stock. This transaction occurred while the stock was experiencing substantial gains. Furthermore, recent corporate disclosures included financial results for the first quarter of 2026 that surpassed analys…